Histochemical and fine structural study of bone of ipriflavone-treated rats
- PMID: 1422980
- DOI: 10.1007/BF02180245
Histochemical and fine structural study of bone of ipriflavone-treated rats
Abstract
Bone labeling, histochemical, and fine structural studies were performed in order to clarify the effects of ipriflavone (IP) on rat bone tissue in vivo and in vitro. Labeling experiments showed a slight increase in bone formation during 3 days' administration. It was also noted that many osteoclasts detached from the bone surface at 1, 2, and 6 hours after administration in vivo. In addition, irregular localization of tartrate-resistant acid phosphatase (TRACPase) activity was observed in osteoclasts. Fine structurally, IP-treated osteoclasts exhibited irregularity in their ruffled borders, as reported in calcitonin administration, and many enlarged rough endoplasmic reticuli and vacuoles were observed. However, osteoclasts at 12 hours after administration, as well as the control, indicated recovery features from the effect of IP. Osteoblast proliferation and differentiation led to increasing alkaline phosphatase activity (ALPase) with time as well as the development of rough endoplasmic reticuli and Golgi apparatus with well-developed fine structure. These findings imply active synthesis of bone matrix. In our in vitro experiment, osteoclasts and osteoblasts displayed histochemical and fine structural characteristics similar to those observed in our in vivo experiment. Moreover, fewer TRACP-positive mononuclear cells were observed after 24-hour culture with IP than with the control. These results suggest that IP inhibits directly and/or indirectly differentiation and activity of osteoclasts and also promotes differentiation of osteoblast-lineage cells and their bone-forming activity.
Similar articles
-
Inhibitory effect of ipriflavone on pit formation in mouse unfractionated bone cells.Calcif Tissue Int. 1992;51 Suppl 1:S3-6. doi: 10.1007/BF02180241. Calcif Tissue Int. 1992. PMID: 1422982
-
Alkaline phosphatase and tartrate-resistant acid phosphatase in osteoblasts of normal and pathologic bone.Ital J Anat Embryol. 2001;106(2 Suppl 1):129-33. Ital J Anat Embryol. 2001. PMID: 11729947 Review.
-
Stimulatory effect of ipriflavone on formation of bone-like tissue in rat bone marrow stromal cell culture.Calcif Tissue Int. 1992;51 Suppl 1:S16-20. doi: 10.1007/BF02180244. Calcif Tissue Int. 1992. PMID: 1422979
-
Alendronate promotes bone formation by inhibiting protein prenylation in osteoblasts in rat tooth replantation model.J Endocrinol. 2013 Oct 4;219(2):145-58. doi: 10.1530/JOE-13-0040. Print 2013 Nov. J Endocrinol. 2013. PMID: 24096963
-
Enzyme histochemistry of bone and cartilage cells.Prog Histochem Cytochem. 1976;8(1):1-38. doi: 10.1016/s0079-6336(76)80010-1. Prog Histochem Cytochem. 1976. PMID: 185660 Review.
Cited by
-
Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells.Calcif Tissue Int. 1993 Sep;53(3):206-9. doi: 10.1007/BF01321839. Calcif Tissue Int. 1993. PMID: 8242474
-
Lack of effect of ipriflavone on osteoclast motility and bone resorption in in vitro and ex vivo studies.Calcif Tissue Int. 1993 Jul;53(1):71. doi: 10.1007/BF01352019. Calcif Tissue Int. 1993. PMID: 8348388 No abstract available.
-
Increase in femoral bone mass by ipriflavone alone and in combination with 1 alpha-hydroxyvitamin D3 in growing rats with skeletal unloading.Calcif Tissue Int. 1996 Feb;58(2):88-94. doi: 10.1007/BF02529729. Calcif Tissue Int. 1996. PMID: 8998683
-
Inhibitory effect of ipriflavone on pit formation in mouse unfractionated bone cells.Calcif Tissue Int. 1992;51 Suppl 1:S3-6. doi: 10.1007/BF02180241. Calcif Tissue Int. 1992. PMID: 1422982
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources